3-70977677-C-T
Variant summary
Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PM1PM2PM5PP3
The NM_001349338.3(FOXP1):c.1394G>A(p.Arg465Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,782 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R465G) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001349338.3 missense
Scores
Clinical Significance
Conservation
Publications
- intellectual disability-severe speech delay-mild dysmorphism syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Illumina, G2P, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
- congenital heart diseaseInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 7 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001349338.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FOXP1 | NM_001349338.3 | MANE Select | c.1394G>A | p.Arg465Lys | missense | Exon 16 of 21 | NP_001336267.1 | ||
| FOXP1 | NM_001244810.2 | c.1394G>A | p.Arg465Lys | missense | Exon 16 of 21 | NP_001231739.1 | |||
| FOXP1 | NM_001244814.3 | c.1394G>A | p.Arg465Lys | missense | Exon 12 of 17 | NP_001231743.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FOXP1 | ENST00000649528.3 | MANE Select | c.1394G>A | p.Arg465Lys | missense | Exon 16 of 21 | ENSP00000497369.1 | ||
| FOXP1 | ENST00000318789.11 | TSL:1 | c.1394G>A | p.Arg465Lys | missense | Exon 16 of 21 | ENSP00000318902.5 | ||
| ENSG00000285708 | ENST00000647725.1 | c.1394G>A | p.Arg465Lys | missense | Exon 21 of 26 | ENSP00000497585.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461782Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727202 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:1
This sequence change replaces arginine, which is basic and polar, with lysine, which is basic and polar, at codon 465 of the FOXP1 protein (p.Arg465Lys). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant disrupts the p.Arg465 amino acid residue in FOXP1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 26647308, 34588003). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FOXP1 protein function. This variant has not been reported in the literature in individuals affected with FOXP1-related conditions. This variant is not present in population databases (gnomAD no frequency).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at